Vortioxetine Impurity 149 CAS CATO-C4X-1056149
| CAS No. | CATO-C4X-1056149 |
| Molecular Formula | C32H37N3S2 |
| Molecular Weight | 527.79 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
As a process- or degradation-related impurity, Vortioxetine Impurity 149 (CAS CATO-C4X-1056149, C32H37N3S2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Based on its molecular formula C32H37N3S2, Vortioxetine Impurity 149 contains a nitrogen-containing heterocyclic scaffold, a nitrile group, sulfur-containing functionality; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 527.79 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
As a certified reference material (CRM), Vortioxetine Impurity 149 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C32H37N3S2 |
| Molecular Weight | 527.79 g/mol |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 16.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 3 |
| Sulfur Atoms | 2 |
Related Vortioxetine Standards
- Vortioxetine Impurity 26 (CAS 2243045-82-9)
- Vortioxetine Impurity 21 (CAS CATO-C4X-105621)
- Vortioxetine Impurity 28 (CAS 2135577-60-3)
- Vortioxetine Impurity 14 (CAS 1240670-85-2)
- Vortioxetine Impurity 58 (CAS CATO-C4X-105658)
- Vortioxetine Impurity 50 (CAS CATO-C4X-105650)
- Vortioxetine Impurity 40 (CAS CATO-C4X-105640)
- Vortioxetine Impurity 53 (CAS CATO-C4X-105653)
Recommended Standards
- (αR,ΔS,γR)-Δ-[[(1,1-Dimethylethoxy)carbonyl]amino]-γ-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-α-(phenylmethyl)benzenehexanoic Acid (CAS 98818-49-6)
- 2-((5-(((4-Chlorophenyl)amino)methyl)-4-methyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-iodo-2-methylphenyl)acetamide (CAS 333314-17-3)
- Ursodeoxycholic Acid impurity 92 (CAS CATO-C4X-142292)
- 3-Benzyl-5-[(1E)-{[(3-chlorophenyl)methoxy]imino}methyl]-1-[(2,4-dichlorophenyl)methyl]-4-hydroxy-1,2-dihydropyridin-2-one (CAS 477888-14-5)
- Nateglinide EP Impurity A (CAS 7077-05-6)
- Cefoxitin Impurity 12 (CAS 40514-94-1)
- Carfilzomib Impurity D3 (CAS CATO-C4X-102258)
- 4-Amino-n-(4-chlorophenyl)butanamide hydrochloride (CAS 1193388-77-0)
- 2-Chloro-N-(2,4,4-trimethylpentan-2-yl)acetamide (CAS 32322-84-2)
- Rucaparib phosphate, 98% (CAS 459868-92-9)
- 4-Cyano-2-(difluoromethyl)-3-(trifluoromethyl)pyridine-6-acetonitrile (CAS 1806993-07-6)
- Methyl 5-(cyanomethyl)furan-2-carboxylate (CAS 39258-67-8)
- 1-(4-Chloro-2-methylphenyl)-3-phenylurea (CAS 13142-67-1)
- D-[Phe6]-Semaglutide (CAS CATO-C4X-2226213)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com